I'm going to side with CDiddy on this sudden call
Post# of 153887
(Total Views: 719)
Posted On: 10/03/2020 1:31:29 PM
I'm going to side with CDiddy on this sudden call for marketing. How many legit small biotechs without an approved drug do you see out there touting their stuff on tv?
Any marketing ploy is asking for a temporary boost in the share price, and very short term sighted. NP has already been on Yahoo Finance, Charles Payne, maybe it provided a small bump...then what? Nothing. We still have no revenue. We've had Samantha Mottet, Dr. Yang on local news stories...maybe a small bump, and now what? Nothing. Gilead got EUA for remdesivir and got a small bump in the 70's and now are flirting with their 52 week low hovering at 62( still a nice div yield) because at the end of the day they are spending like crazy trying to upgrade their portfolio due to lagging sales in their flagship Hep C(and soon to be ailing HIV :o) )
At the end of the day investing in the things that get you to that revenue mean more. You know how many times I've told my wife about the drug and she still can't remember the name? How is a small time tv spot gonna be any different? She doesn't follow the company like I do.
We want to fill trials faster? have a product that works. Dr. Recknor found out it works and helped fill our trials faster.
Obviously my opinion and if DR. NP decides to do marketing fine, but per the CC he's learned his lesson. These PR agencies promise the world, and all of them stunk(don't get anyone started on RedChip). He's not getting burned again and I applaud that...thats one area he has learned from past issues.
Undeniable S/C results will give us all the free marketing we will ever need.
Any marketing ploy is asking for a temporary boost in the share price, and very short term sighted. NP has already been on Yahoo Finance, Charles Payne, maybe it provided a small bump...then what? Nothing. We still have no revenue. We've had Samantha Mottet, Dr. Yang on local news stories...maybe a small bump, and now what? Nothing. Gilead got EUA for remdesivir and got a small bump in the 70's and now are flirting with their 52 week low hovering at 62( still a nice div yield) because at the end of the day they are spending like crazy trying to upgrade their portfolio due to lagging sales in their flagship Hep C(and soon to be ailing HIV :o) )
At the end of the day investing in the things that get you to that revenue mean more. You know how many times I've told my wife about the drug and she still can't remember the name? How is a small time tv spot gonna be any different? She doesn't follow the company like I do.
We want to fill trials faster? have a product that works. Dr. Recknor found out it works and helped fill our trials faster.
Obviously my opinion and if DR. NP decides to do marketing fine, but per the CC he's learned his lesson. These PR agencies promise the world, and all of them stunk(don't get anyone started on RedChip). He's not getting burned again and I applaud that...thats one area he has learned from past issues.
Undeniable S/C results will give us all the free marketing we will ever need.
(2)
(0)